Mangoceuticals, Inc. entered into multiple consulting agreements and issued shares of restricted common stock, including 150,000 shares to Veritas Consulting, 195,000 shares to Levo Healthcare, and 650,000 shares to Luca Consulting, while also selling 2,000,000 shares for $521,016 under an equity purchase agreement with Platinum Point Capital.